Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: A useful tool in myotonic dystrophy type 1

S. Iachettini, R. Valaperta, A. Marchesi, A. Perfetti, G. Cuomo, B. Fossati, L. Vaienti, E. Costa, G. Meola, Rosanna Cardani

Research output: Contribution to journalArticle

Abstract

Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by a CTG repeat expansion in 3’UTR of DMPK gene. This mutation causes accumulation of toxic RNA in nuclear foci leading to splicing misregulation of specific genes. In view of future clinical trials with antisense oligonucleotides in DM1 patients, it is important to set up sensitive and minimally-invasive tools to monitor the efficacy of treatments on skeletal muscle. A tibialis anterior (TA) muscle sample of about 60 mg was obtained from 5 DM1 patients and 5 healthy subjects through a needle biopsy. A fragment of about 40 mg was used for histological examination and a fragment of about 20 mg was used for biomolecular analysis. The TA fragments obtained with the minimally-invasive needle biopsy technique is enough to perform all the histopathological and biomolecular evaluations useful to monitor a clinical trial on DM1 patients.

Original languageEnglish
Article numberA01
Pages (from-to)243-249
Number of pages7
JournalEuropean journal of histochemistry : EJH
Volume59
Issue number4
DOIs
Publication statusPublished - 2015

Keywords

  • alternative splicing
  • clinical trial
  • Myotonic dystrophy type 1
  • needle biopsy
  • Tibialis anterior

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Biophysics

Fingerprint Dive into the research topics of 'Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: A useful tool in myotonic dystrophy type 1'. Together they form a unique fingerprint.

  • Cite this